Truvada News and Research

RSS
UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

First large-scale clinical study of long-acting injectable HIV drug begins

First large-scale clinical study of long-acting injectable HIV drug begins

Study explores men's perceptions of new HIV prevention treatment

Study explores men's perceptions of new HIV prevention treatment

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

New method estimates patient adherence to antiretroviral drugs

New method estimates patient adherence to antiretroviral drugs

Study provides new insights into real-world use of PrEP

Study provides new insights into real-world use of PrEP

Study confirms efficacy of PrEP in reducing risk of HIV infection in men who have sex with men

Study confirms efficacy of PrEP in reducing risk of HIV infection in men who have sex with men

HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

NHS England takes too long to commission PrEP for HIV prevention

NHS England takes too long to commission PrEP for HIV prevention

Women need antiviral medication Truvada more than men to prevent HIV infection

Women need antiviral medication Truvada more than men to prevent HIV infection

Maraviroc drug safe, well-tolerated when taken as PrEP to prevent HIV infection

Maraviroc drug safe, well-tolerated when taken as PrEP to prevent HIV infection

Results from phase 3 women-only HIV study show improved safety, efficacy of Stribild drug

Results from phase 3 women-only HIV study show improved safety, efficacy of Stribild drug

HIV prevention program undergoes “real world” evaluation

HIV prevention program undergoes “real world” evaluation

Young, single South African women adhere well to daily PrEP regimen to prevent HIV infection

Young, single South African women adhere well to daily PrEP regimen to prevent HIV infection

US health care providers reluctant to prescribe HIV prevention plan

US health care providers reluctant to prescribe HIV prevention plan

HIV Prevention Trials Network launches two phase 2 studies to evaluate new HIV drugs

HIV Prevention Trials Network launches two phase 2 studies to evaluate new HIV drugs

NIH-sponsored clinical trials examine safety, acceptability of HIV antiretroviral medicines

NIH-sponsored clinical trials examine safety, acceptability of HIV antiretroviral medicines

Dosing of antiretroviral medication to prevent HIV infection differs by sex

Dosing of antiretroviral medication to prevent HIV infection differs by sex